We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIG icon
226
Hartford Financial Services
HIG
$38.5B
$3.65M 0.09%
82,260
-68,002
-45% -$3.04M
EQT icon
227
EQT Corp
EQT
$33.2B
$3.57M 0.09%
84,653
-20,234
-19% -$787K
SWKS icon
228
Skyworks Solutions
SWKS
$9.06B
$3.56M 0.09%
56,219
-32,187
-36% -$2.19M
F icon
229
Ford
F
$57.3B
$3.51M 0.09%
279,206
+9,807
+4% +$129K
NRG icon
230
NRG Energy
NRG
$29.8B
$3.51M 0.09%
+234,092
New +$3.47M
BAC icon
231
Bank of America
BAC
$435B
$3.42M 0.09%
257,807
-11,764
-4% -$165K
ICPT
232
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.28M 0.09%
23,000
-15,000
-39% -$2.19M
NOV icon
233
NOV
NOV
$7.45B
$3.22M 0.08%
95,749
+47,950
+100% +$1.54M
BHI
234
DELISTED
Baker Hughes
BHI
$3.09M 0.08%
68,560
+44,574
+186% +$2.02M
INTU icon
235
Intuit
INTU
$81.1B
$3.08M 0.08%
27,592
-50
-0.2% -$5.23K
UGI icon
236
UGI
UGI
$8B
$3.03M 0.08%
+67,031
New +$2.82M
ARRY
237
DELISTED
Array Biopharma Inc
ARRY
$3.02M 0.08%
849,000
+190,000
+29% +$619K
AMT icon
238
American Tower
AMT
$77.7B
$2.98M 0.08%
26,257
+1,397
+6% +$149K
TEVA icon
239
Teva Pharmaceuticals
TEVA
$35.9B
$2.97M 0.08%
59,199
-1,354
-2% -$72.1K
CNP icon
240
CenterPoint Energy
CNP
$29.1B
$2.96M 0.08%
+123,140
New +$2.72M
KMB icon
241
Kimberly-Clark
KMB
$36.4B
$2.94M 0.08%
21,401
+4,308
+25% +$564K
RARE icon
242
Ultragenyx Pharmaceutical
RARE
$2.65B
$2.94M 0.08%
60,000
-4,000
-6% -$259K
WBA
243
DELISTED
Walgreens Boots Alliance
WBA
$2.91M 0.08%
34,941
+7,938
+29% +$641K
SGEN
244
DELISTED
Seagen Inc. Common Stock
SGEN
$2.89M 0.08%
71,500
-38,500
-35% -$1.46M
AMAT icon
245
Applied Materials
AMAT
$426B
$2.89M 0.08%
120,477
+64,977
+117% +$1.43M
GS icon
246
Goldman Sachs
GS
$313B
$2.87M 0.07%
19,282
+2,101
+12% +$328K
ELGX
247
DELISTED
Endologix Inc
ELGX
$2.83M 0.07%
+22,700
New +$2.61M
MRSH
248
Marsh
MRSH
$86.3B
$2.79M 0.07%
40,802
+1,036
+3% +$66.5K
CMA
249
DELISTED
Comerica
CMA
$2.79M 0.07%
67,825
-446,203
-87% -$19M
ONCE
250
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.76M 0.07%
54,000
+24,000
+80% +$1.03M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.